These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 9656399)

  • 1. Granulocyte-macrophage colony-stimulating factor production by T lymphocytes in Plasmodium berghei-infected mice.
    Owhashi M; Uemura H; Kanbara H; Nawa Y
    Southeast Asian J Trop Med Public Health; 1997 Dec; 28(4):757-63. PubMed ID: 9656399
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Temporary appearance of a circulating granulocyte-macrophage colony-stimulating factor in lethal murine malaria.
    Owhashi M; Kirai N; Asami M
    Southeast Asian J Trop Med Public Health; 1996 Sep; 27(3):530-4. PubMed ID: 9185264
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A plasmid encoding murine granulocyte-macrophage colony-stimulating factor increases protection conferred by a malaria DNA vaccine.
    Weiss WR; Ishii KJ; Hedstrom RC; Sedegah M; Ichino M; Barnhart K; Klinman DM; Hoffman SL
    J Immunol; 1998 Sep; 161(5):2325-32. PubMed ID: 9725227
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lactoferrin acts on I-A and I-E/C antigen+ subpopulations of mouse peritoneal macrophages in the absence of T lymphocytes and other cell types to inhibit production of granulocyte-macrophage colony stimulatory factors in vitro.
    Broxmeyer HE; Platzer E
    J Immunol; 1984 Jul; 133(1):306-14. PubMed ID: 6144710
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interleukin 18 inhibits osteoclast formation via T cell production of granulocyte macrophage colony-stimulating factor.
    Horwood NJ; Udagawa N; Elliott J; Grail D; Okamura H; Kurimoto M; Dunn AR; Martin T; Gillespie MT
    J Clin Invest; 1998 Feb; 101(3):595-603. PubMed ID: 9449693
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasmodium berghei XAT: contribution of gammadelta T cells to host defense against infection with blood-stage nonlethal malaria parasite.
    Kobayashi F; Niikura M; Waki S; Matsui T; Fujino T; Tsuruhara T; Kamiya S
    Exp Parasitol; 2007 Dec; 117(4):368-75. PubMed ID: 17601562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Induction of G250-targeted and T-cell-mediated antitumor activity against renal cell carcinoma using a chimeric fusion protein consisting of G250 and granulocyte/monocyte-colony stimulating factor.
    Tso CL; Zisman A; Pantuck A; Calilliw R; Hernandez JM; Paik S; Nguyen D; Gitlitz B; Shintaku PI; de Kernion J; Figlin R; Belldegrun A
    Cancer Res; 2001 Nov; 61(21):7925-33. PubMed ID: 11691814
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hydrocortisone inhibits granulocyte-macrophage colony-stimulating factor production from normal human peripheral blood mononuclear cells and CD3+ T cells.
    Chikkappa G; Lansing LS; Chu RC; Pasquale D
    Exp Hematol; 1998 Dec; 26(13):1240-6. PubMed ID: 9845380
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of antibody production in vitro by granulocyte-macrophage colony stimulating factor.
    Grabstein K; Mochizuki D; Kronheim S; Price V; Cosman D; Urdal D; Gillis S; Conlon P
    J Mol Cell Immunol; 1986; 2(4):199-207. PubMed ID: 3334416
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative studies of the effects of recombinant GM-CSF and GM-CSF administered via a poxvirus to enhance the concentration of antigen- presenting cells in regional lymph nodes.
    Kass E; Parker J; Schlom J; Greiner JW
    Cytokine; 2000 Jul; 12(7):960-71. PubMed ID: 10880241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 1 alpha,25-dihydroxyvitamin D3 plus gamma-interferon blocks lung tumor production of granulocyte-macrophage colony-stimulating factor and induction of immunosuppressor cells.
    Young MR; Halpin J; Wang J; Wright MA; Matthews J; Pak AS
    Cancer Res; 1993 Dec; 53(24):6006-10. PubMed ID: 8261414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Granulocyte/macrophage-colony stimulating factor produced by recombinant avian poxviruses enriches the regional lymph nodes with antigen-presenting cells and acts as an immunoadjuvant.
    Kass E; Panicali DL; Mazzara G; Schlom J; Greiner JW
    Cancer Res; 2001 Jan; 61(1):206-14. PubMed ID: 11196163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Injection of DNA encoding granulocyte-macrophage colony-stimulating factor recruits dendritic cells for immune adjuvant effects.
    Bowne WB; Wolchok JD; Hawkins WG; Srinivasan R; Gregor P; Blachere NE; Moroi Y; Engelhorn ME; Houghton AN; Lewis JJ
    Cytokines Cell Mol Ther; 1999 Dec; 5(4):217-25. PubMed ID: 10850386
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of the functional properties of murine dendritic cells generated in vivo with Flt3 ligand, GM-CSF and Flt3 ligand plus GM-SCF.
    Daro E; Butz E; Smith J; Teepe M; Maliszewski CR; McKenna HJ
    Cytokine; 2002 Feb; 17(3):119-30. PubMed ID: 11895330
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of immune suppression in patients with head and neck cancer: presence of CD34(+) cells which suppress immune functions within cancers that secrete granulocyte-macrophage colony-stimulating factor.
    Pak AS; Wright MA; Matthews JP; Collins SL; Petruzzelli GJ; Young MR
    Clin Cancer Res; 1995 Jan; 1(1):95-103. PubMed ID: 9815891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in dendritic cells stimulated in vivo by tumors engineered to secrete granulocyte-macrophage colony-stimulating factor or Flt3-ligand.
    Mach N; Gillessen S; Wilson SB; Sheehan C; Mihm M; Dranoff G
    Cancer Res; 2000 Jun; 60(12):3239-46. PubMed ID: 10866317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epidermal Langerhans cells from mice bearing a granulocyte macrophage-colony stimulating factor-producing mammary tumor display impaired accessory functions.
    Xie Y; Fernandez ME; Streilein JW; Lopez DM
    Anticancer Res; 1996; 16(1):9-16. PubMed ID: 8615675
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sustained release of granulocyte-macrophage colony-stimulating factor from a modular peptide-based cancer vaccine alters vaccine microenvironment and enhances the antigen-specific T-cell response.
    Nguyen CL; Bui JT; Demcheva M; Vournakis JN; Cole DJ; Gillanders WE
    J Immunother; 2001; 24(5):420-9. PubMed ID: 11696697
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prevention of cerebral malaria by adoptive transfer of malaria-specific cultured T cells into mice infected with Plasmodium berghei.
    Finley R; Weintraub J; Louis JA; Engers HD; Zubler R; Lambert PH
    J Immunol; 1983 Sep; 131(3):1522-6. PubMed ID: 6224859
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Granulocyte-macrophage colony-stimulating factor produced by an inducible murine T-cell hybridoma: molecular properties and cellular specificity.
    Burgess AW; Bartlett PF; Metcalf D; Nicola NA; Clark-Lewis I; Schrader JW
    Exp Hematol; 1981 Oct; 9(9):893-903. PubMed ID: 6978261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.